2020
DOI: 10.1177/0218492320965015
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound versus thoracoscopic-guided paravertebral block during thoracotomy

Abstract: Background Paravertebral block can be performed with the aid of surgical landmarks, ultrasound, or a thoracoscope. This study was designed to compare ultrasound-guided paravertebral block with the thoracoscopic technique. Methods This prospective randomized comparative study included 40 adults scheduled for elective thoracic surgery. Study participants were randomized to an ultrasound group or a thoracoscope group. A catheter for paravertebral block was inserted prior to thoracotomy with real-time ultrasound v… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 20 publications
0
5
0
Order By: Relevance
“…Interestingly, there was no significant difference in the incidence of complications among the four groups. These findings suggest that ropivacaine alone and 0.5 μ g·kg −1 dexmedetomidine plus ropivacaine cannot effectively inhibit the intubation reaction of patients during surgery, while the doses of 1.0 μ g·kg −1 and 1.5 μ g·kg −1 dexmedetomidine plus ropivacaine can effectively reduce and control hemodynamics [ 18 ]. This may have been due to that the doses of 1.0 μ g·kg −1 and 1.5 μ g·kg −1 dexmedetomidine play a key role in reducing and controlling the stress response of patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Interestingly, there was no significant difference in the incidence of complications among the four groups. These findings suggest that ropivacaine alone and 0.5 μ g·kg −1 dexmedetomidine plus ropivacaine cannot effectively inhibit the intubation reaction of patients during surgery, while the doses of 1.0 μ g·kg −1 and 1.5 μ g·kg −1 dexmedetomidine plus ropivacaine can effectively reduce and control hemodynamics [ 18 ]. This may have been due to that the doses of 1.0 μ g·kg −1 and 1.5 μ g·kg −1 dexmedetomidine play a key role in reducing and controlling the stress response of patients.…”
Section: Discussionmentioning
confidence: 99%
“…This would suggest that 1.0 μ g·kg −1 and 1.5 μ g·kg −1 doses of dexmedetomidine combined with ropivacaine exert good sedative and analgesic effects, without prolonging the recovery time of patients or raising the risk of complications [ 19 ]. The possible mechanism is that (1) dexmedetomidine, as a μ -opioid receptor agonist, can effectively block the release of norepinephrine, thereby weakening nerve signal transmission and ultimately reducing postoperative adverse symptoms such as hyperalgesia [ 18 ]; (2) dexmedetomidine can also reduce interleukin and inflammatory factors such as tumor necrosis factors, reduce the excitability of nerves, and thus reduce the pain of patients [ 19 ]; (3) dexmedetomidine can enhance the sympathetic nerve activity of patients and inhibit the occurrence of postoperative hyperalgesia from both positive and negative aspects [ 20 ]; (4) dexmedetomidine also has a certain antinociceptive effect, which further relieves pain and improves the sedation degree of patients [ 21 ].…”
Section: Discussionmentioning
confidence: 99%
“…Incisional infiltration to block the anterior serratus is also commonly used to reduce postoperative pain. The advantage of this technique is that it can provide prolonged pain relief, has a low probability of local anesthetic poisoning and complications, and is relatively simple to perform [ 23 25 ].…”
Section: Discusionmentioning
confidence: 99%
“…[11][12][13][14][15] Paravertebral (PV) catheterbased regional anesthesia is regarded as one of the most promising options for providing regional anesthesia in cardiac surgical patients and has been studied in depth for patients undergoing thoracic surgical procedures. [14][15][16][17] Nevertheless, further research is required to identify its efficacy and safety profile in patients undergoing MICS.…”
Section: Central Messagementioning
confidence: 99%